Loss of TET1 expression due to DAC treatment has also been found in chronic lymphocytic leukemia cells (Kopparapu et al., 2017) and can be at least partially responsible for DAC-induced hypermethylation. Here, TET1 is linked to B-cell chronic lymphocytic leukemia.